WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS

DRINKING WATER PRODUCTS

For both disinfection and TOC-reduction applications, NeoTech Aqua Solutions’ patented ReFleX™ UV chamber technology represents the state-of-the-art in high-efficiency UV systems by reflecting over 99% of the UV we generate back into the water.

As PFAS and other emerging contaminants of concern are increasingly regulated, De Nora is developing new and effective methods for addressing CECs, innovating for the future.

We arm farmers with mission-critical water data to help enhance crop yield and taste. KETOS delivers valuable insights for fluctuations in deficiency and toxicity.

Desalination is the process of removing salt from sea water or brackish river or groundwater to make potable water. By YSI

WesTech’s SuperDisc™ Disc Filter from Nordic Water is a Title 22 approved inside-out disc filter.The SuperDisc provides easy access for maintenance and has an efficient high pressure cleaning system. The small footprint and low head required for the filter provides an excellent option for tertiary retrofits, such as travelling bridge sand filters. The SuperDisc can produce reuse-quality effluent and total effluent phosphorus concentrations of less than 0.1 mg/L. Other applications include primary and secondary treatment, as well as a wide range of industrial applications. The SuperDisc filter is available as a freestanding unit with filter discs contained in a stainless steel tank and a version for installation in a concrete basin.

EPRO™ LMF Series are engineered our from the ground up to provide maximum treatment efficiency in a compact, skidded package. This series of RO systems removes impurities, such as bacteria and dissolved solids, from source water, including brackish water. Available configurations deliver permeate flow rates of 21 to 60 GPM (30,000 to 86,400 GPD) to address the diverse requirements of light industrial applications and commercial users.

VIEWS ON THE LATEST REGS

  • With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
  • A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.

  • Assessing what lies ahead in the 10-year race to go lead-free, otherwise known as the Lead and Copper Rule Improvements (LCRI).
  • Many water systems are still tackling the challenge of identifying and compliantly managing galvanized and galvanized-requiring-replacement (GRR) service lines.

  • In the most recent edition of Water Innovations, there is not a single article focused on PFAS. That wouldn't be exceptional if not for the fact that discussion around per- and polyfluoroalkyl substances has so thoroughly dominated the water space lately. And yet, I penned this as an intro to the edition — just "a tiny bit of PFAS" content — because a small portion of PFAS is of the utmost importance in terms of treatment, policy, and cost.

MORE WATER INDUSTRY FEATURES

  • Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.

  • As public awareness of per- and polyfluoroalkyl substances (PFAS) grows, so too does concern over their widespread presence in our water, soil, food, and even our bodies. Rapid, on-site, or remotely operated detection of these “forever chemicals” is a crucial step to understanding the levels of PFAS within our systems.

  • Selecting primary packaging for biologics requires evaluating formulation type, administration route, dosing needs, and stability to ensure safe, effective, home‑use‑ready drug products.

  • Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.